ENZON PHARMACEUTICALS, INC. Quarterly Common Stock, Shares Authorized from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Enzon Pharmaceuticals, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q4 2010 to Q2 2024.
  • Enzon Pharmaceuticals, Inc. Common Stock, Shares Authorized for the quarter ending June 30, 2024 was 170M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 170M 0 0% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 170M 0 0% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 170M 0 0% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 170M 0 0% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 170M 0 0% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 170M 0 0% Mar 31, 2023 10-Q 2023-05-05
Q4 2022 170M 0 0% Dec 31, 2022 10-K 2024-03-20
Q3 2022 170M 0 0% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 170M 0 0% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 170M 0 0% Mar 31, 2022 10-Q 2022-04-26
Q4 2021 170M 0 0% Dec 31, 2021 10-K 2023-02-16
Q3 2021 170M 0 0% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 170M 0 0% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 170M 0 0% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 170M 0 0% Dec 31, 2020 10-K 2022-02-25
Q3 2020 170M 0 0% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 170M 0 0% Jun 30, 2020 10-Q 2020-07-29
Q1 2020 170M 0 0% Mar 31, 2020 10-Q 2020-04-30
Q4 2019 170M 0 0% Dec 31, 2019 10-K 2021-02-23
Q3 2019 170M 0 0% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 170M 0 0% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 170M 0 0% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 170M 0 0% Dec 31, 2018 10-K 2020-02-19
Q3 2018 170M 0 0% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 170M 0 0% Jun 30, 2018 10-Q 2018-08-10
Q1 2018 170M 0 0% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 170M 0 0% Dec 31, 2017 10-K 2019-02-21
Q3 2017 170M 0 0% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 170M 0 0% Jun 30, 2017 10-Q 2017-08-10
Q1 2017 170M 0 0% Mar 31, 2017 10-Q 2017-05-11
Q4 2016 170M 0 0% Dec 31, 2016 10-K 2018-03-21
Q3 2016 170M 0 0% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 170M 0 0% Jun 30, 2016 10-Q 2016-08-10
Q1 2016 170M 0 0% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 170M 0 0% Dec 31, 2015 10-K 2017-03-24
Q3 2015 170M 0 0% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 170M 0 0% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 170M 0 0% Mar 31, 2015 10-Q 2015-05-13
Q4 2014 170M 0 0% Dec 31, 2014 10-K 2016-03-21
Q3 2014 170M 0 0% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 170M 0 0% Jun 30, 2014 10-Q 2014-08-08
Q1 2014 170M 0 0% Mar 31, 2014 10-Q 2014-05-09
Q4 2013 170M 0 0% Dec 31, 2013 10-K 2015-03-05
Q3 2013 170M 0 0% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 170M 0 0% Jun 30, 2013 10-Q 2013-08-06
Q1 2013 170M 0 0% Mar 31, 2013 10-Q 2013-05-10
Q4 2012 170M 0 0% Dec 31, 2012 10-K 2014-03-14
Q3 2012 170M 0 0% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 170M 0 0% Jun 30, 2012 10-Q/A 2012-08-21
Q1 2012 170M Mar 31, 2012 10-Q 2012-05-02
Q4 2011 170M 0 0% Dec 31, 2011 10-K 2013-03-18
Q3 2011 170M Sep 30, 2011 10-Q 2011-11-04
Q2 2011 170M Jun 30, 2011 10-Q 2011-08-05
Q4 2010 170M Dec 31, 2010 10-K 2012-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.